HIPRA

Company Premium

HIPRA is a biotechnological pharmaceutical company focused on prevention for animal and human health, with a broad range of highly innovative vaccines and an advanced diagnostic service.

A company that works with the latest technological advances to create innovative solutions that improve world health.

R&D projects are the basis of the knowledge. HIPRA has more than 50 years of experience dedicated to the research and development of different vaccines. With a unique organizational model, HIPRA controls all the processes of the value chain, generating singular know-how and becoming a reference in the research, production, and commercialization of biologics.

HIPRA has a solid international presence, commercial subsidiaries and a global distribution network, allowing products to reach costumers from more than 100 countries, covering the 5 continents.

Send message

Danish national PRRS reduction strategy - Status year 1

By May 2023, 85% of all Danish pig herds have a serological PRRS status. Area eradication programs have been established in regions with a high density of PRRS seropositive herds. The Danish Agriculture & Food Council has taken a range of initiatives with the purpose of paving the road for a national reduction of PRRS, including an implementation strategy, digital tools, common guidelines for the classification, monitoring, and eradication of PRRSV, and project funding resources.

Welcome to 333

Connect, share, and interact with the largest community of professionals in the swine industry.

Celebrating 152103Users on 333!

Sign upAlready a member?
Recommended accounts
Zhou  Lydia

Zhou Lydia

Other - China
DAVI  LIOU

DAVI LIOU

Other - China
DanBred

DanBred

Company - Denmark
Boehringer Ingelheim Vetmedica GmbH
Company - Germany
Vietstock Expo & Forum EN
Company - Vietnam